Chad Winters

CIK: 0001811424

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (8.3%)

Position reduction

Option Exercises (M)3 (25.0%)

Derivative conversions

Awards (A)5 (41.7%)

Compensation grants

Other (G, F, J, C, D, …)3 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

WST

WEST PHARMACEUTICAL SERVICES INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

WST
WEST PHARMACEUTICAL SERVICES INC
Apr 27, 2026
Exercise(M)
Direct
896 shares at avg. $173.22$155K
WST
WEST PHARMACEUTICAL SERVICES INC
Apr 27, 2026
Sale(S)
Direct
896 shares at avg. $300.67$269K
WST
WEST PHARMACEUTICAL SERVICES INC
Mar 1, 2026
Award(A)
Stock Option (Right to Buy)
Direct
808 shares-
WST
WEST PHARMACEUTICAL SERVICES INC
Mar 1, 2026
Award(A)
Rst. Stock Unit
Direct
340 shares-
WST
WEST PHARMACEUTICAL SERVICES INC
Feb 20, 2026
Tax Payment(F)
Direct
30 shares at avg. $241.12$7K
WST
WEST PHARMACEUTICAL SERVICES INC
Feb 20, 2026
Exercise(M)
Direct
89 shares-
WST
WEST PHARMACEUTICAL SERVICES INC
Feb 17, 2026
Tax Payment(F)
Direct
51 shares at avg. $243.19$12K
WST
WEST PHARMACEUTICAL SERVICES INC
Feb 17, 2026
Award(A)
Direct
150 shares-
WST
WEST PHARMACEUTICAL SERVICES INC
Feb 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
822 shares-
WST
WEST PHARMACEUTICAL SERVICES INC
Feb 18, 2025
Award(A)
Rst. Stock Unit
Direct
356 shares-
WST
WEST PHARMACEUTICAL SERVICES INC
Feb 18, 2025
Exercise(M)
Direct
82 shares at avg. $211.00$17K
WST
WEST PHARMACEUTICAL SERVICES INC
Feb 18, 2025
Tax Payment(F)
Direct
28 shares at avg. $211.00$6K

		Type	Shares	Price		Ownership
Apr 27, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Exercise(M)	896	$173.22	$155,205	Direct
Apr 27, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Sale(S)	896	$300.67	$269,399	Direct
Mar 1, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Stock Option (Right to Buy)	808	-	-	Direct
Mar 1, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Rst. Stock Unit	340	-	-	Direct
Feb 20, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Tax Payment(F)	30	$241.12	$7,278	Direct
Feb 20, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Exercise(M)	89	-	$0	Direct
Feb 17, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Tax Payment(F)	51	$243.19	$12,300	Direct
Feb 17, 2026	WST WEST PHARMACEUTICAL SERVICES INC	Award(A)	150	-	$0	Direct
Feb 18, 2025	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Stock Option (Right to Buy)	822	-	-	Direct
Feb 18, 2025	WST WEST PHARMACEUTICAL SERVICES INC	Award(A) Rst. Stock Unit	356	-	-	Direct
Feb 18, 2025	WST WEST PHARMACEUTICAL SERVICES INC	Exercise(M)	82	$211.00	$17,313	Direct
Feb 18, 2025	WST WEST PHARMACEUTICAL SERVICES INC	Tax Payment(F)	28	$211.00	$5,850	Direct

1-12 of 12 transactions

About Winters Chad

Winters Chad (SEC CIK 0001811424) files insider reports with the SEC as VP, Chief Accounting Officer of WEST PHARMACEUTICAL SERVICES INC (WST).

Signal8 holds 5 ownership filings by Winters Chad, all Form 4s, filed between Feb 20, 2025 and Apr 29, 2026. Those filings report 12 transactions, from Feb 18, 2025 to Apr 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Winters Chad's filings is in EXTON, PA.

Recent filings by Winters Chad

Apr 27, 2026: Option exercise of WST shares (Form 4, code M).
Apr 27, 2026: Open-market sale of WST shares (Form 4, code S).
Mar 1, 2026: Grants or awards of WST derivative securities (2 lines, Form 4, code A).
Feb 20, 2026: Tax withholding of WST shares (Form 4, code F).
Feb 20, 2026: Option exercise of WST shares (Form 4, code M).

Other insiders filing for WEST PHARMACEUTICAL SERVICES INC (WST)

HAUGEN JANET BRUTSCHEA, Director
Favorite Annette F, Sr. VP & Chief HR Officer
Lagarde Michel, President and CEO
McMahon Robert W., SVP & Chief Financial Officer
Campbell Shane Alden, SVP, Proprietary Segment
Pucci Paolo, Director

How to read Form 4 transaction codes